Detection of methylated SEPT9 in plasma is a reliable screening method for both left- and right-sided colon cancers.

PloS One
Kinga TóthBéla Molnár

Abstract

Methylated Septin 9 (SEPT9) is a sensitive biomarker for colorectal cancer (CRC) from peripheral blood. However, its relationship to cancer localization, guaiac-based fecal occult blood test (gFOBT) and carcinoembryonic antigen (CEA) have not been described. Plasma samples were collected for SEPT9 analysis from patients with no evidence of disease (NED) (n=92) before colonoscopy and CRC (n=92) before surgical treatment. DNA was isolated and bisulfite-converted using Epi proColon kit 2.0. Qualitative determination was performed using Epi proColon 2.0 RT-PCR assay. Samples for gFOBT and CEA analysis were collected from NED (n=17 and 27, respectively) and CRC (n=22 and 27, respectively). SEPT9 test was positive in 15.2% (14/92) of NED and 95.6% (88/92) of CRC, including 100% (67/67) from stage II to stage IV CRC and 84% (21/25) of stage I CRC when a sample was called positive if 1 out of 3 PCR replicates was positive. In a second analysis (2 out of 3 PCR replicates) specificity improved to 99% (91/92) of NEDs, at a sensitivity of 79.3% (73/92) of SEPT9 positives in CRC. gFOBT was positive in 29.4% (5/17) of NED and 68.2% (15/22) of CRC and elevated CEA levels were detected in 14.8% (4/27) of NED and 51.8% (14/27) of CRC. Both SEPT...Continue Reading

References

Oct 1, 1991·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·J Hardcastle
Dec 1, 1995·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·P RozenN Papo
Oct 10, 2001·The Journal of Pathology·E KapiteijnJ H van Krieken
Oct 21, 2004·The Journal of Pathology·Peter A Hall, S E Hilary Russell
May 25, 2006·JAMA : the Journal of the American Medical Association·Harminder SinghCharles N Bernstein
Oct 25, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gershon Y LockerUNKNOWN ASCO
Jan 27, 2007·The Cochrane Database of Systematic Reviews·P HewitsonE Watson
May 30, 2007·Journal of Gastroenterology and Hepatology·Toru NawaYasushi Shiratori
Dec 20, 2007·Clinical Chemistry·Catherine Lofton-DayAndrew Sledziewski
Jul 16, 2008·Annals of Surgical Oncology·Robert A MeguidNita Ahuja
Sep 19, 2008·The New England Journal of Medicine·C Daniel JohnsonPaul J Limburg
Oct 8, 2008·Annals of the New York Academy of Sciences·Ugur DeligezerNejat Dalay
Dec 17, 2008·Annals of Internal Medicine·Nancy N BaxterLinda Rabeneck
May 2, 2009·Clinical Chemistry·Theo deVosCatherine Lofton-Day
May 26, 2009·Current Opinion in Gastroenterology·David Lieberman
Sep 18, 2009·The New England Journal of Medicine·David A Lieberman
Feb 25, 2010·Clinical Chemistry and Laboratory Medicine : CCLM·Jinn-Shiun ChenErr-Cheng Chan
May 1, 2010·Lancet·Wendy S AtkinUNKNOWN UK Flexible Sigmoidoscopy Trial Investigators
Aug 28, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Norbert WildJohann Karl
Jan 5, 2011·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·F BenedixUNKNOWN Study Group "Colon/Rectum Carcinoma (Primary Tumor)"
Feb 8, 2011·CA: a Cancer Journal for Clinicians·Ahmedin JemalDavid Forman
Mar 23, 2011·Journal of the National Cancer Institute·Pragatheeshwar ThirunavukarasuDavid L Bartlett
Jun 10, 2011·Molecular Carcinogenesis·Kerry M BauerSteven Buechler
Oct 5, 2011·CA: a Cancer Journal for Clinicians·Carol DeSantisAhmedin Jemal
Oct 5, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jennifer M WeissMaureen A Smith
Dec 16, 2011·BMC Medicine·Jorja D WarrenKaren A Heichman
Jan 18, 2012·Journal of Gastroenterology·Sam GhaziUNKNOWN Low-Risk Colorectal Cancer Study Group
Jun 23, 2012·Digestive Diseases·Arpád V PataiZsolt Tulassay

❮ Previous
Next ❯

Citations

Dec 7, 2013·Molecular Diagnosis & Therapy·Karen A Heichman
Sep 26, 2013·International Journal of Molecular Sciences·Yahya I ElshimaliJaydutt V Vadgama
Sep 24, 2013·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Melina-Theoni GyparakiAthanasios G Papavassiliou
Jun 21, 2013·Expert Review of Molecular Diagnostics·Juan SandovalJosé Luis García-Giménez
Nov 28, 2014·Expert Review of Molecular Diagnostics·Béla MolnárZsolt Tulassay
Dec 15, 2015·Expert Review of Molecular Diagnostics·Kinga TóthBéla Molnár
Mar 26, 2014·Expert Opinion on Drug Metabolism & Toxicology·Alfonso Dueñas-GonzalezAurora Gonzalez-Fierro
Nov 7, 2013·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Qingfan YangJun Yu
Nov 14, 2015·Journal of Digestive Diseases·Meng XueLiang Jing Wang
May 23, 2014·International Journal of Clinical Practice·R A Stein
Dec 20, 2014·Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society·Rajvinder SinghTakashia Matsuda
Dec 5, 2014·Journal of Gastroenterology and Hepatology·Peng JinJian-qiu Sheng
Jul 23, 2013·Epigenetics : Official Journal of the DNA Methylation Society·Vladimir A NaumovVadim M Govorun
Jun 2, 2016·Epigenetics : Official Journal of the DNA Methylation Society·Orsolya GalambBéla Molnár
Mar 21, 2015·PloS One·Kim Y C FungLeah J Cosgrove
Dec 4, 2014·PloS One·Keishi YamashitaMasahiko Watanabe
Jan 6, 2017·Translational Research : the Journal of Laboratory and Clinical Medicine·Jessica A HowellRohini Sharma
Jul 29, 2017·Epigenetics : Official Journal of the DNA Methylation Society·Barbara Kinga BartákBéla Molnár
Dec 6, 2017·Expert Review of Anticancer Therapy·Anthony LopezJaffer A Ajani
Dec 12, 2017·Critical Reviews in Clinical Laboratory Sciences·José Luis García-GiménezFederico V Pallardó
Sep 19, 2018·Technology in Cancer Research & Treatment·Na HeKaichun Wu
Jan 20, 2017·Clinical and Translational Gastroenterology·Jiayun NianXiaomin Wang
Mar 1, 2018·Journal of Translational Medicine·Micaela FreitasCarmen Jerónimo
Feb 6, 2013·Nature Reviews. Clinical Oncology·Ernst J KuipersMichael Bretthauer
Feb 15, 2015·Digestive Diseases and Sciences·Robert S BresalierDean E Brenner
Jul 8, 2020·Journal of Cellular and Molecular Medicine·Reza KhayamiMohammad Amin Kerachian

❮ Previous
Next ❯

Methods Mentioned

BETA
X-ray
biopsies
deamination
PCR
surgical resection

Software Mentioned

R
Epi proColon

Related Concepts

Related Feeds

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Related Papers

Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
Alexandre R Zlotta
Gut
Timothy Robert ChurchPRESEPT Clinical Study Steering Committee, Investigators and Study Team
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
William HamiltonUna Macleod
© 2021 Meta ULC. All rights reserved